HomeDNLI • NASDAQ
Follow
Denali Therapeutics Inc
Previous close
$17.34
Day range
$16.79 - $17.56
Year range
$15.45 - $33.31
Market cap
2.40B USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 24.77M | 5.33% |
Net income | -119.47M | -21.07% |
Net profit margin | — | — |
Earnings per share | -0.86 | -14.67% |
EBITDA | -130.37M | -28.75% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.03B | -22.58% |
Total assets | 1.15B | -20.98% |
Total liabilities | 122.96M | -70.57% |
Total equity | 1.03B | — |
Shares outstanding | 139.16M | — |
Price to book | 2.33 | — |
Return on assets | -27.73% | — |
Return on capital | -29.39% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -119.47M | -21.07% |
Cash from operations | -98.66M | -35.77% |
Cash from investing | 73.05M | 157.27% |
Cash from financing | 4.70M | -98.43% |
Net change in cash | -20.90M | -121.03% |
Free cash flow | -54.27M | -29.08% |
About
Founded
2013
Headquarters
Website
Employees
445